NO20026177L - Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel - Google Patents

Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel

Info

Publication number: NO20026177L
Authority: NO; Norway
Prior art keywords: optionally; reducing agent; beta blocker; new formulation; cholesterol reducing
Prior art date: 2000-06-22

Application number

NO20026177A

Other languages

English (en)

Norwegian (no)

Other versions

NO20026177D0 (no

Inventor

Goeran Berglund

John Wikstrand

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-22

Filing date

2002-12-20

Publication date

2002-12-20

2002-12-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-12-20 Publication of NO20026177D0 publication Critical patent/NO20026177D0/no

2002-12-20 Publication of NO20026177L publication Critical patent/NO20026177L/no

Links

HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 2
239000002876 beta blocker Substances 0.000 title 1
229940097320 beta blocking agent Drugs 0.000 title 1
239000003638 chemical reducing agent Substances 0.000 title 1
235000012000 cholesterol Nutrition 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)
Pyrane Compounds (AREA)
Pyrrole Compounds (AREA)

NO20026177A 2000-06-22 2002-12-20 Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel NO20026177L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0002354A SE0002354D0 (sv)	2000-06-22	2000-06-22	New formulation
PCT/SE2001/001380 WO2001097751A2 (en)	2000-06-22	2001-06-15	New formulation comprising a betablocker and optionally a cholesterol-lowering agent

Publications (2)

Publication Number	Publication Date
NO20026177D0 NO20026177D0 (no)	2002-12-20
NO20026177L true NO20026177L (no)	2002-12-20

Family

ID=20280209

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20026177A NO20026177L (no)	2000-06-22	2002-12-20	Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel

Country Status (28)

Country	Link
US (2)	US20030191177A1 (de)
EP (1)	EP1296716B1 (de)
JP (1)	JP2003535875A (de)
KR (1)	KR20030010750A (de)
CN (1)	CN1437484A (de)
AR (1)	AR028699A1 (de)
AT (1)	ATE344675T1 (de)
AU (1)	AU2001274766A1 (de)
BG (1)	BG107373A (de)
BR (1)	BR0111790A (de)
CA (1)	CA2411100A1 (de)
CZ (1)	CZ20024181A3 (de)
DE (1)	DE60124400T2 (de)
EE (1)	EE200200703A (de)
ES (1)	ES2274892T3 (de)
HK (1)	HK1054508A1 (de)
HU (1)	HUP0302371A3 (de)
IL (1)	IL153245A0 (de)
IS (1)	IS6653A (de)
MX (1)	MXPA02012957A (de)
NO (1)	NO20026177L (de)
NZ (1)	NZ523188A (de)
PL (1)	PL360484A1 (de)
RU (1)	RU2271802C2 (de)
SE (1)	SE0002354D0 (de)
SK (1)	SK18072002A3 (de)
WO (1)	WO2001097751A2 (de)
ZA (1)	ZA200209908B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007512347A (ja) *	2003-11-26	2007-05-17	デューク・ユニバーシティー	緑内障を予防するかまたは治療する方法
KR100582347B1 (ko) *	2004-12-30	2006-05-22	한미약품 주식회사	3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
KR100836321B1 (ko)	2006-10-31	2008-06-09	현대자동차주식회사	차량용 모니터 장치
US8703178B2 (en) *	2007-03-08	2014-04-22	Nitto Denko Corporation	Percutaneous administration device of bisoprolol

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5175187A (en) *	1989-03-06	1992-12-29	Soorianarain Baligadoo	Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) *	1989-03-06	1995-10-03	Baligadoo; Soorianarain	Synergistic compositions of amiodarone and beta blockers
CA2106494A1 (en) *	1991-03-18	1992-09-19	James W. Young	Composition and method containing optically pure (s) metoprolol
JP2648897B2 (ja) *	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体
NO177455C (no) *	1993-06-04	1995-09-20	Gerrit Elmenhorst	Anordning ved apparat for fremstilling av brannslukkende skum
JP2000508659A (ja) *	1996-04-17	2000-07-11	メルクエンドカンパニーインコーポレーテッド	心血管疾患関連の危険性を低減する組み合わせ療法
SE9602762D0 (sv) *	1996-07-12	1996-07-12	Astra Ab	Carton and blank for forming the same
US5998458A (en) *	1997-06-25	1999-12-07	University Technology Corporation	Method of treating heart failure
GT199800126A (es) *	1997-08-29	2000-01-29		Terapia de combinacion.
DE69911058T2 (de) *	1998-12-23	2004-06-03	G.D. Searle Llc, Chicago	Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen

2000
- 2000-06-22 SE SE0002354A patent/SE0002354D0/xx unknown
2001
- 2001-06-11 AR ARP010102759A patent/AR028699A1/es not_active Application Discontinuation
- 2001-06-15 EP EP01941409A patent/EP1296716B1/de not_active Expired - Lifetime
- 2001-06-15 KR KR1020027017474A patent/KR20030010750A/ko not_active Withdrawn
- 2001-06-15 HK HK03106811.1A patent/HK1054508A1/zh unknown
- 2001-06-15 AU AU2001274766A patent/AU2001274766A1/en not_active Abandoned
- 2001-06-15 NZ NZ523188A patent/NZ523188A/en unknown
- 2001-06-15 BR BR0111790-4A patent/BR0111790A/pt not_active IP Right Cessation
- 2001-06-15 EE EEP200200703A patent/EE200200703A/xx unknown
- 2001-06-15 CZ CZ20024181A patent/CZ20024181A3/cs unknown
- 2001-06-15 RU RU2002133205/15A patent/RU2271802C2/ru not_active IP Right Cessation
- 2001-06-15 HU HU0302371A patent/HUP0302371A3/hu unknown
- 2001-06-15 AT AT01941409T patent/ATE344675T1/de not_active IP Right Cessation
- 2001-06-15 JP JP2002503228A patent/JP2003535875A/ja active Pending
- 2001-06-15 PL PL36048401A patent/PL360484A1/xx not_active Application Discontinuation
- 2001-06-15 IL IL15324501A patent/IL153245A0/xx unknown
- 2001-06-15 SK SK1807-2002A patent/SK18072002A3/sk unknown
- 2001-06-15 CA CA002411100A patent/CA2411100A1/en not_active Abandoned
- 2001-06-15 US US10/311,201 patent/US20030191177A1/en not_active Abandoned
- 2001-06-15 WO PCT/SE2001/001380 patent/WO2001097751A2/en not_active Ceased
- 2001-06-15 ES ES01941409T patent/ES2274892T3/es not_active Expired - Lifetime
- 2001-06-15 MX MXPA02012957A patent/MXPA02012957A/es unknown
- 2001-06-15 CN CN01811540A patent/CN1437484A/zh active Pending
- 2001-06-15 DE DE60124400T patent/DE60124400T2/de not_active Expired - Fee Related
2002
- 2002-12-05 ZA ZA200209908A patent/ZA200209908B/en unknown
- 2002-12-11 IS IS6653A patent/IS6653A/is unknown
- 2002-12-11 BG BG107373A patent/BG107373A/bg unknown
- 2002-12-20 NO NO20026177A patent/NO20026177L/no not_active Application Discontinuation
2006
- 2006-04-19 US US11/407,505 patent/US20060252814A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2271802C2 (ru)	2006-03-20
ZA200209908B (en)	2004-03-05
EP1296716A2 (de)	2003-04-02
WO2001097751A2 (en)	2001-12-27
CN1437484A (zh)	2003-08-20
NO20026177D0 (no)	2002-12-20
IL153245A0 (en)	2003-07-06
EE200200703A (et)	2004-08-16
AU2001274766A1 (en)	2002-01-02
HUP0302371A2 (hu)	2003-11-28
IS6653A (is)	2002-12-11
DE60124400T2 (de)	2007-10-31
BR0111790A (pt)	2003-05-20
EP1296716B1 (de)	2006-11-08
US20030191177A1 (en)	2003-10-09
WO2001097751A3 (en)	2002-03-28
HUP0302371A3 (en)	2007-03-28
BG107373A (bg)	2003-09-30
AR028699A1 (es)	2003-05-21
MXPA02012957A (es)	2003-05-15
KR20030010750A (ko)	2003-02-05
JP2003535875A (ja)	2003-12-02
SK18072002A3 (sk)	2003-08-05
ES2274892T3 (es)	2007-06-01
SE0002354D0 (sv)	2000-06-22
DE60124400D1 (de)	2006-12-21
CA2411100A1 (en)	2001-12-27
ATE344675T1 (de)	2006-11-15
PL360484A1 (en)	2004-09-06
US20060252814A1 (en)	2006-11-09
HK1054508A1 (zh)	2003-12-05
NZ523188A (en)	2006-06-30
CZ20024181A3 (cs)	2003-04-16

Legal Events

Date	Code	Title	Description
2008-01-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20022086D0 (no)	2002-05-02	Antidiabetisk formulering og fremgangsmåte
DK1216247T3 (da)	2009-02-23	Imidazoimidazoler og triazoler som anti-inflammatoriske midler
NL1016224A1 (nl)	2001-03-22	Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
EP1275398A4 (de)	2004-09-01	Diagnostische- und arzneimittel zur behandlung von rheumatoide arthriten
DK1339292T3 (da)	2010-04-12	Sammensætning og fremgangsmåde
DK1278763T3 (da)	2007-06-11	3-Nitrogen-6,7-dioxygensteroider og anvendelser relateret dertil
FI991297L (fi)	2000-12-08	Liikkuvuusagentin valinta accessverkossa
NO20015931D0 (no)	2001-12-04	Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin
DK1112003T3 (da)	2003-08-04	Ny sammensætning og anvendelse
DK1173434T3 (da)	2003-12-08	Thiazolidindionderivat og dets anvendelse som antidiabetisk middel
NO20025158D0 (no)	2002-10-25	Lipidpreparat og anvendelse derav
AU2001276149A1 (en)	2002-06-27	Cleaning and disinfecting agent
NO20030759D0 (no)	2003-02-18	10-aryl-11-HBENZO(b)fluorenderivater og analoger for medisinsk anvendelse
NO20025968D0 (no)	2002-12-12	Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav
FI19992513L (fi)	2001-05-26	Menetelmä ja laite rullanvaihdossa
NO20022438D0 (no)	2002-05-23	Tampong med dekke og ikke-ionisk surfaktant
NO20023144L (no)	2002-12-30	Et kompleks som omfatter OCIF og polysakkarid
NO20004904L (no)	2000-11-29	C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som medikamenter
NO20026177D0 (no)	2002-12-20	Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel
NO20005763L (no)	2001-01-10	DHEA-sammensetning og fremgangsmåte
AU4427201A (en)	2001-09-24	Noise-abatement structure and its constituting elements
GB0020427D0 (en)	2000-10-04	Moem device and fabrication method
EE200100404A (et)	2002-10-15	Kolesterooli alandava agensi kasutamine
DK1173436T3 (da)	2004-09-27	Thiazolidindionderivat og anvendelse deraf som antidiabetikum
DE50106974D1 (de)	2005-09-08	Aufbereitungs- und applikationsvorrichtung für implantatmaterialien